- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03173586
Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
Association Between Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will analyze cross-sectional data from 8,492 participants in the Nurses' Health Study who were free of diabetes and cardiovascular disease to evaluate the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages (ASB) and biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control. Biomarkers were measured from blood samples that were collected in 2 cycles, approximately 10 years apart.
Specifically, multivariate linear regression will be used to assess the associations of SSB, ASB, and fruit juice intake with concentrations of fetuin-A, alanine transaminase, gamma-glutamyl transferase, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol, C-reactive protein (CRP), intracellular adhesion molecule 1 (ICAM-1), vascular cell adhesion protein 1 (VCAM-1), adiponectin, insulin, and hemoglobin A1c as well as total cholesterol/HDL-C ratio.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Harvard T.H. Chan School of Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
For the current study, we included participants who provided a blood sample and were previously selected as controls for nested case-control analyses of type 2 diabetes, coronary heart disease, stroke, colon cancer, colon polyps, pancreatic cancer, and breast cancer in the Nurse's Health Study.
Exclusion Criteria:
Participants with self-reported prevalent diabetes or cardiovascular disease (CVD) at blood draw were excluded. After exclusions, a total of 8,492 individuals (6,961 from cycle 1 and 1,531 from cycle 2) with valid beverage intake data were included in the current analysis.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
NHS
Least-squares mean (95% CI) concentrations of biomarkers by frequency of sugar sweetened beverage (SSB) intake among participants free of diabetes and cardiovascular disease in the NHS. Least-squares mean (95% CI) concentrations of biomarkers by frequency of artificially sweetened beverage (ASB) intake among participants free of diabetes and cardiovascular disease in the NHS. Least-squares mean (95% CI) concentrations of biomarkers by frequency of fruit juice intake among participants free of diabetes and cardiovascular disease in the NHS. |
This is an observational study examining sugar sweetened beverage intake in relation to biomarkers in the NHS.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fetuin-A
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of liver function
|
Blood collection cycle 1 (1989-1990)
|
Fetuin-A
Time Frame: Blood collection cyle 2 (2000-2001)
|
Biomarkers of liver function
|
Blood collection cyle 2 (2000-2001)
|
Alanine transaminase
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of liver function
|
Blood collection cycle 1 (1989-1990)
|
Alanine transaminase
Time Frame: Blood collection cyle 2 (2000-2001)
|
Biomarkers of liver function
|
Blood collection cyle 2 (2000-2001)
|
Gamma-glutamyl transferase
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of liver function
|
Blood collection cycle 1 (1989-1990)
|
Gamma-glutamyl transferase
Time Frame: Blood collection cyle 2 (2000-2001)
|
Biomarkers of liver function
|
Blood collection cyle 2 (2000-2001)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Triglycerides
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 1 (1989-1990)
|
Triglycerides
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 2 (2000-2001)
|
High-density lipoprotein cholesterol (HDL-C)
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 1 (1989-1990)
|
High-density lipoprotein cholesterol (HDL-C)
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 2 (2000-2001)
|
Low-density lipoprotein cholesterol (LDL-C)
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 1 (1989-1990)
|
Low-density lipoprotein cholesterol (LDL-C)
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 2 (2000-2001)
|
Total cholesterol
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 1 (1989-1990)
|
Total cholesterol
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 2 (2000-2001)
|
Total cholesterol/HDL-C ratio
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 1 (1989-1990)
|
Total cholesterol/HDL-C ratio
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of lipid metabolism
|
Blood collection cycle 2 (2000-2001)
|
C-reactive protein (CRP)
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of inflammation
|
Blood collection cycle 1 (1989-1990)
|
C-reactive protein (CRP)
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of inflammation
|
Blood collection cycle 2 (2000-2001)
|
Intracellular adhesion molecule 1 (ICAM-1)
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of inflammation
|
Blood collection cycle 1 (1989-1990)
|
Intracellular adhesion molecule 1 (ICAM-1)
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of inflammation
|
Blood collection cycle 2 (2000-2001)
|
Vascular cell adhesion protein 1 (VCAM-1)
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of inflammation
|
Blood collection cycle 1 (1989-1990)
|
Vascular cell adhesion protein 1 (VCAM-1)
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of inflammation
|
Blood collection cycle 2 (2000-2001)
|
Insulin
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of glucose metabolism
|
Blood collection cycle 1 (1989-1990)
|
Insulin
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of glucose metabolism
|
Blood collection cycle 2 (2000-2001)
|
Hemoglobin A1c
Time Frame: Blood collection cycle 1 (1989-1990)
|
Biomarkers of glucose metabolism
|
Blood collection cycle 1 (1989-1990)
|
Hemoglobin A1c
Time Frame: Blood collection cycle 2 (2000-2001)
|
Biomarkers of glucose metabolism
|
Blood collection cycle 2 (2000-2001)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Vasanti Malik, ScD, Research Scientist
Publications and helpful links
General Publications
- Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002 Mar;75(3):492-8. doi: 10.1093/ajcn/75.3.492.
- Pan A, Malik VS, Hao T, Willett WC, Mozaffarian D, Hu FB. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes (Lond). 2013 Oct;37(10):1378-85. doi: 10.1038/ijo.2012.225. Epub 2013 Jan 15.
- de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr. 2011 Jun;93(6):1321-7. doi: 10.3945/ajcn.110.007922. Epub 2011 Mar 23.
- Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR Jr. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2009 Apr;32(4):688-94. doi: 10.2337/dc08-1799. Epub 2009 Jan 16.
- Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr. 2013 Oct;98(4):1084-102. doi: 10.3945/ajcn.113.058362. Epub 2013 Aug 21.
- Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004 Aug 25;292(8):927-34. doi: 10.1001/jama.292.8.927.
- Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985 Jul;122(1):51-65. doi: 10.1093/oxfordjournals.aje.a114086.
- Malik VS, Chiuve SE, Campos H, Rimm EB, Mozaffarian D, Hu FB, Sun Q. Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease in US Men and Women. Circulation. 2015 Jul 28;132(4):260-8. doi: 10.1161/CIRCULATIONAHA.114.014911. Epub 2015 Jun 5.
- Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010 Nov;33(11):2477-83. doi: 10.2337/dc10-1079. Epub 2010 Aug 6.
- Xi B, Huang Y, Reilly KH, Li S, Zheng R, Barrio-Lopez MT, Martinez-Gonzalez MA, Zhou D. Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. Br J Nutr. 2015 Mar 14;113(5):709-17. doi: 10.1017/S0007114514004383. Epub 2015 Mar 4.
- de Koning L, Malik VS, Kellogg MD, Rimm EB, Willett WC, Hu FB. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation. 2012 Apr 10;125(14):1735-41, S1. doi: 10.1161/CIRCULATIONAHA.111.067017. Epub 2012 Mar 12.
- Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care. 2008 Jul;31(7):1311-7. doi: 10.2337/dc08-0080. Epub 2008 Apr 4.
- Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989 Dec;18(4):858-67. doi: 10.1093/ije/18.4.858.
- Ley SH, Sun Q, Jimenez MC, Rexrode KM, Manson JE, Jensen MK, Rimm EB, Hu FB. Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women. Diabetologia. 2014 Jan;57(1):93-101. doi: 10.1007/s00125-013-3077-8. Epub 2013 Oct 9.
- Nimptsch K, Brand-Miller JC, Franz M, Sampson L, Willett WC, Giovannucci E. Dietary insulin index and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Am J Clin Nutr. 2011 Jul;94(1):182-90. doi: 10.3945/ajcn.110.009555. Epub 2011 May 4.
- Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes. 2013 Jan;62(1):49-55. doi: 10.2337/db12-0372. Epub 2012 Aug 24.
- Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr. 2009 Apr;89(4):1037-42. doi: 10.3945/ajcn.2008.27140. Epub 2009 Feb 11.
- Pan A, Malik VS, Schulze MB, Manson JE, Willett WC, Hu FB. Plain-water intake and risk of type 2 diabetes in young and middle-aged women. Am J Clin Nutr. 2012 Jun;95(6):1454-60. doi: 10.3945/ajcn.111.032698. Epub 2012 May 2.
- AlEssa HB, Ley SH, Rosner B, Malik VS, Willett WC, Campos H, Hu FB. High Fiber and Low Starch Intakes Are Associated with Circulating Intermediate Biomarkers of Type 2 Diabetes among Women. J Nutr. 2016 Feb;146(2):306-17. doi: 10.3945/jn.115.219915. Epub 2016 Jan 13.
- Yu Z, Malik VS, Keum N, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS, Bao Y. Associations between nut consumption and inflammatory biomarkers. Am J Clin Nutr. 2016 Sep;104(3):722-8. doi: 10.3945/ajcn.116.134205. Epub 2016 Jul 27.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1999-P-011114
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biomarkers
-
Peking UniversityCompleted
-
University of MinnesotaCompleted
-
University of California, DavisUSDA, Western Human Nutrition Research CenterRecruiting
-
West China HospitalRecruitingBiomarkers | NeonateChina
-
U.S. Army Medical Research and Development CommandWalter Reed Army Institute of Research (WRAIR)CompletedBiomarkers, PharmacologicalUnited States
-
Five Liters, Inc.Northwell Health; The Feinstein Institutes for Medical ResearchRecruitingHemostasis | Blood BiomarkersUnited States
-
CareDxRecruitingLiver Transplantation | BiomarkersUnited States
-
Washington State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedInteraction | Endogenous BiomarkersUnited States
-
Claudine MANACHNational Research Agency, FranceCompletedBiomarkers | Food IntakeFrance
-
The Netherlands Cancer InstituteUnknownDrug Safety BiomarkersNetherlands
Clinical Trials on Sugar sweetened beverage (SSB)
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedCardiovascular Diseases | Hypertension | Healthy | Obesity | Diabetes | Overweight | Metabolic Syndrome | PreDiabetes | Overweight and Obesity | Cardiovascular Risk Factor | DysglycemiaCanada
-
Pennington Biomedical Research CenterCorby K. Martin; Owen T. CarmichaelCompleted
-
University of California, DavisEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminated
-
University of MichiganCompleted
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | OverweightUnited States
-
NYU Langone HealthCompletedObesity | Type 2 Diabetes | Dental CariesUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI); Robert Wood Johnson FoundationCompleted
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompleted
-
UConn HealthUniversity of ConnecticutCompletedChildhood ObesityUnited States
-
University of PennsylvaniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New... and other collaboratorsTerminated